Document is current
Any future updates will be listed below
-
Authors
Tommerdahl, Kalie L.
Shapiro, Allison L. B.
Nehus, Edward J.
Bjornstad, Petter http://orcid.org/0000-0002-5160-2947
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (5T32DK007135-46, K01DK120562, DK116720)
ISPAD-JDRF Research Fellowship
Center for Women's Health Research at University of Colorado Anschutz Medical Campus
Lifecourse Epidemiology of Adiposity and Diabetes Center at the University of Colorado
National Institute of Diabetes and Digestive and Kidney Diseases (DK114886)
Juvenile Diabetes Research Foundation International (2-SRA-2019-845-S-B, 3-SRA-2017-424-M-B)
American Heart Association (20IPA35260142)
Boettcher Foundation
Center for Women's Health Research at the University of Colorado Anschutz Medical Campus
Department of Pediatrics, Section of Endocrinology
Department of Pediatrics, Section of Endocrinology
Barbara Davis Center for Diabetes
- License Information
-
More Information
Article History
Received: 15 December 2020
Revised: 1 March 2021
Accepted: 9 March 2021
First Online: 14 April 2021
Declarations
:
: KLT, ALBS, and EJN have nothing to disclose. PB has acted as a consultant for AstraZeneca, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Eli-Lilly, Sanofi, Novo Nordisk and Horizon Pharma. PB serves on the advisory boards for AstraZeneca, Bayer, Boehringer Ingelheim, Novo Nordisk and XORTX.
